Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.36
-0.51 (-4.69%)
At close: Nov 13, 2026, 4:00 PM EST
9.62
-0.74 (-7.16%)
After-hours: Nov 13, 2026, 7:30 PM EST
Climb Bio Employees
As of December 31, 2025, Climb Bio had 29 total employees, including 28 full-time and 1 part-time employees. The number of employees increased by 11 or 61.11% compared to the previous year. That makes Climb Bio the 37,256th largest employer in the world and 5,183rd in the United States.
Employees
29
Change (1Y)
11
Growth (1Y)
61.11%
Revenue / Employee
n/a
Profits / Employee
-$2,045,138
Market Cap
608.53M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 29 | 11 | 61.11% | 28 | 1 |
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| Wave Life Sciences | 317 |
| Kura Oncology | 260 |
| 4D Molecular Therapeutics | 196 |
| DBV Technologies | 179 |
| Prime Medicine | 146 |
| Bicara Therapeutics | 103 |
| ArriVent BioPharma | 77 |
| Zevra Therapeutics | 61 |
CLYM News
- 3 days ago - Climb Bio management to meet with B. Riley - TheFly
- 3 days ago - Climb Bio price target raised to $26 from $20 at Freedom Broker - TheFly
- 4 days ago - Climb Bio Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 7 days ago - Climb Bio price target raised to $27 from $25 at Wedbush - TheFly
- 8 days ago - Climb Bio files automatic mixed securities shelf - TheFly
- 8 days ago - Climb Bio reports Q3 EPS (19c), consensus (19c) - TheFly
- 9 days ago - Climb Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 9 days ago - Climb Bio Quarterly report: Q3 2026 - Filings